Belgium· BE-AMP-SAM665287-00
Rezdiffra 100 mg
A resmetirom product containing resmetirom, registered in Belgium by Madrigal Pharmaceuticals EU. The same ATC class is registered in 9 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Resmetirom is registered in 9 of 19 countries.
Countries holding a registration under ATC A05BA11 (resmetirom), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Resmetirom · ATC A05BA11
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Resmetirom
- Manufacturer
- Madrigal Pharmaceuticals EU
- Country
- Belgium (BE)
- ATC code
- A05BA11
- ATC class
- Resmetirom
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Resmetirom in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaREZDIFFRAMadrigal Pharmaceuticals EU Limited, Dublin
- SpainREZDIFFRA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMadrigal Pharmaceuticals Eu Limited
- FinlandRezdiffraMadrigal Pharmaceuticals EU Limited
- FranceREZDIFFRA 100 mg, comprimé pelliculéMADRIGAL PHARMACEUTICALS EU (IRLANDE)
- IrelandRezdiffra 100 mg film-coated tabletsMadrigal Pharmaceuticals EU Limited
- IcelandRezdiffraMadrigal Pharmaceuticals EU Limited
- NetherlandsRezdiffra 100 mg filmomhulde tablettenMadrigal Pharmaceuticals EU Limited
- PolandRezdiffraMadrigal Pharmaceuticals EU Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b350d231-b362-4245-94e2-31efcf10ae9a GET /v1/drugs/b350d231-b362-4245-94e2-31efcf10ae9a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Rezdiffra 100 mg",
"name_fr": "Rezdiffra 100 mg",
"name_nl": "Rezdiffra 100 mg",
"amp_code": "SAM665287-00",
"strengths": [
"100.0000",
"100.0000"
],
"pack_count": 1,
"substances": [
"Resmetirom",
"Mannitol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Resmetirom",
"authorisation_numbers": [
"EU/1/25/1962/003"
]
}See everything about resmetirom.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.